EMEA (Europe, Middle East and Africa) Oncology Drugs Market Report 2017

Table of Contents

EMEA (Europe, Middle East and Africa) Oncology Drugs Market Report 2017
1 Oncology Drugs Overview
1.1 Product Overview and Scope of Oncology Drugs
1.2 Classification of Oncology Drugs
1.2.1 EMEA Oncology Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Oncology Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Oral Therapy
1.2.4 Injectable Therapy
1.3 EMEA Oncology Drugs Market by Application/End Users
1.3.1 EMEA Oncology Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Targeted Therapy
1.3.3 Chemotherapy
1.3.4 Hormonal Therapy
1.3.5 Biologic Therapy
1.4 EMEA Oncology Drugs Market by Region
1.4.1 EMEA Oncology Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oncology Drugs (2012-2022)
1.5.1 EMEA Oncology Drugs Sales and Growth Rate (2012-2022)
1.5.2 EMEA Oncology Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Oncology Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Oncology Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA Oncology Drugs Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Oncology Drugs Revenue and Share by Players (2012-2017)
2.1.3 EMEA Oncology Drugs Sale Price by Players (2012-2017)
2.2 EMEA Oncology Drugs (Volume and Value) by Type/Product Category
2.2.1 EMEA Oncology Drugs Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Oncology Drugs Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Oncology Drugs Sale Price by Type (2012-2017)
2.3 EMEA Oncology Drugs (Volume) by Application
2.4 EMEA Oncology Drugs (Volume and Value) by Region
2.4.1 EMEA Oncology Drugs Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Oncology Drugs Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Oncology Drugs Sales Price by Region (2012-2017)

3 Europe Oncology Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Oncology Drugs Sales and Value (2012-2017)
3.1.1 Europe Oncology Drugs Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Oncology Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Oncology Drugs Sales and Market Share by Type
3.3 Europe Oncology Drugs Sales and Market Share by Application
3.4 Europe Oncology Drugs Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Oncology Drugs Sales Volume by Countries (2012-2017)
3.4.2 Europe Oncology Drugs Revenue by Countries (2012-2017)
3.4.3 Germany Oncology Drugs Sales and Growth Rate (2012-2017)
3.4.4 France Oncology Drugs Sales and Growth Rate (2012-2017)
3.4.5 UK Oncology Drugs Sales and Growth Rate (2012-2017)
3.4.6 Russia Oncology Drugs Sales and Growth Rate (2012-2017)
3.4.7 Italy Oncology Drugs Sales and Growth Rate (2012-2017)
3.4.8 Benelux Oncology Drugs Sales and Growth Rate (2012-2017)

4 Middle East Oncology Drugs (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Oncology Drugs Sales and Value (2012-2017)
4.1.1 Middle East Oncology Drugs Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Oncology Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Oncology Drugs Sales and Market Share by Type
4.3 Middle East Oncology Drugs Sales and Market Share by Application
4.4 Middle East Oncology Drugs Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Oncology Drugs Sales Volume by Countries (2012-2017)
4.4.2 Middle East Oncology Drugs Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Oncology Drugs Sales and Growth Rate (2012-2017)
4.4.4 Israel Oncology Drugs Sales and Growth Rate (2012-2017)
4.4.5 UAE Oncology Drugs Sales and Growth Rate (2012-2017)
4.4.6 Iran Oncology Drugs Sales and Growth Rate (2012-2017)

5 Africa Oncology Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Oncology Drugs Sales and Value (2012-2017)
5.1.1 Africa Oncology Drugs Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Oncology Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Oncology Drugs Sales and Market Share by Type
5.3 Africa Oncology Drugs Sales and Market Share by Application
5.4 Africa Oncology Drugs Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Oncology Drugs Sales Volume by Countries (2012-2017)
5.4.2 Africa Oncology Drugs Revenue by Countries (2012-2017)
5.4.3 South Africa Oncology Drugs Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Oncology Drugs Sales and Growth Rate (2012-2017)
5.4.5 Egypt Oncology Drugs Sales and Growth Rate (2012-2017)
5.4.6 Algeria Oncology Drugs Sales and Growth Rate (2012-2017)

6 EMEA Oncology Drugs Manufacturers/Players Profiles and Sales Data
6.1 Novartis A.G
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oncology Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Novartis A.G Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Laboratrio Cristlia
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Oncology Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Laboratrio Cristlia Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Medley Genomics
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Oncology Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Medley Genomics Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 F. Hoffmann-La Roche Ltd
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Oncology Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 F. Hoffmann-La Roche Ltd Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Icon Plc.
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Oncology Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Icon Plc. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Sanofi S.A.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Oncology Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sanofi S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Laboratoires Pierre Fabre
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Oncology Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Laboratoires Pierre Fabre Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Eurofarma Laboratrios S.A.
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Oncology Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eurofarma Laboratrios S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Ach Laboratrios Farmacuticos S.A.
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Oncology Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Laboratorios IMA
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Oncology Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Laboratorios IMA Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Oncology Drugs Manufacturing Cost Analysis
7.1 Oncology Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oncology Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oncology Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Oncology Drugs Market Forecast (2017-2022)
11.1 EMEA Oncology Drugs Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Oncology Drugs Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Oncology Drugs Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Oncology Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Oncology Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Oncology Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Oncology Drugs
Figure EMEA Oncology Drugs Sales Volume (MT) by Type (2012-2022)
Figure EMEA Oncology Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Therapy Product Picture
Figure Injectable Therapy Product Picture
Figure EMEA Oncology Drugs Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Oncology Drugs by Application in 2016
Figure Targeted Therapy Examples
Table Key Downstream Customer in Targeted Therapy
Figure Chemotherapy Examples
Table Key Downstream Customer in Chemotherapy
Figure Hormonal Therapy Examples
Table Key Downstream Customer in Hormonal Therapy
Figure Biologic Therapy Examples
Table Key Downstream Customer in Biologic Therapy
Figure EMEA Oncology Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oncology Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Oncology Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Oncology Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Oncology Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Oncology Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Oncology Drugs Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Oncology Drugs Sales Share by Players (2012-2017)
Figure 2016 Oncology Drugs Sales Share by Players
Figure 2017 Oncology Drugs Sales Share by Players
Figure EMEA Oncology Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Oncology Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Oncology Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Oncology Drugs Revenue Share by Players
Table 2017 EMEA Oncology Drugs Revenue Share by Players
Table EMEA Oncology Drugs Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA Oncology Drugs Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Oncology Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Oncology Drugs by Type (2012-2017)
Figure EMEA Oncology Drugs Sales Market Share by Type (2012-2017)
Table EMEA Oncology Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Oncology Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology Drugs by Type in 2016
Table EMEA Oncology Drugs Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA Oncology Drugs Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Oncology Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Oncology Drugs by Application (2012-2017)
Figure EMEA Oncology Drugs Sales Market Share by Application in 2016
Table EMEA Oncology Drugs Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Oncology Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Oncology Drugs by Region (2012-2017)
Figure EMEA Oncology Drugs Sales Market Share in 2016
Table EMEA Oncology Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Oncology Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Oncology Drugs by Region (2012-2017)
Figure EMEA Oncology Drugs Revenue Market Share Regions in 2016
Table EMEA Oncology Drugs Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Europe Oncology Drugs Revenue and Growth Rate (2012-2017)
Table Europe Oncology Drugs Sales (MT) by Type (2012-2017)
Table Europe Oncology Drugs Market Share by Type (2012-2017)
Figure Europe Oncology Drugs Market Share by Type in 2016
Table Europe Oncology Drugs Sales (MT) by Application (2012-2017)
Table Europe Oncology Drugs Market Share by Application (2012-2017)
Figure Europe Oncology Drugs Market Share by Application in 2016
Table Europe Oncology Drugs Sales (MT) by Countries (2012-2017)
Table Europe Oncology Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Oncology Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Oncology Drugs Sales Market Share by Countries in 2016
Table Europe Oncology Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Oncology Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Oncology Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Oncology Drugs Revenue Market Share by Countries in 2016
Figure Germany Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure France Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UK Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Russia Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Italy Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Oncology Drugs Sales (MT) by Type (2012-2017)
Table Middle East Oncology Drugs Market Share by Type (2012-2017)
Figure Middle East Oncology Drugs Market Share by Type (2012-2017)
Table Middle East Oncology Drugs Sales (MT) by Applications (2012-2017)
Table Middle East Oncology Drugs Market Share by Applications (2012-2017)
Figure Middle East Oncology Drugs Sales Market Share by Application in 2016
Table Middle East Oncology Drugs Sales Volume (MT) by Countries (2012-2017)
Table Middle East Oncology Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Oncology Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Oncology Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Oncology Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Oncology Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Oncology Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Israel Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UAE Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Iran Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Oncology Drugs Sales (MT) by Type (2012-2017)
Table Africa Oncology Drugs Sales Market Share by Type (2012-2017)
Figure Africa Oncology Drugs Sales Market Share by Type (2012-2017)
Figure Africa Oncology Drugs Sales Market Share by Type in 2016
Table Africa Oncology Drugs Sales (MT) by Application (2012-2017)
Table Africa Oncology Drugs Sales Market Share by Application (2012-2017)
Figure Africa Oncology Drugs Sales Market Share by Application (2012-2017)
Table Africa Oncology Drugs Sales Volume (MT) by Countries (2012-2017)
Table Africa Oncology Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Oncology Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Oncology Drugs Sales Market Share by Countries in 2016
Table Africa Oncology Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Oncology Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Oncology Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Oncology Drugs Revenue Market Share by Countries in 2016
Figure South Africa Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Table Novartis A.G Oncology Drugs Basic Information List
Table Novartis A.G Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis A.G Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Novartis A.G Oncology Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis A.G Oncology Drugs Revenue Market Share in EMEA (2012-2017)
Table Laboratrio Cristlia Oncology Drugs Basic Information List
Table Laboratrio Cristlia Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Laboratrio Cristlia Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Laboratrio Cristlia Oncology Drugs Sales Market Share in EMEA (2012-2017)
Figure Laboratrio Cristlia Oncology Drugs Revenue Market Share in EMEA (2012-2017)
Table Medley Genomics Oncology Drugs Basic Information List
Table Medley Genomics Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Medley Genomics Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Medley Genomics Oncology Drugs Sales Market Share in EMEA (2012-2017)
Figure Medley Genomics Oncology Drugs Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Ltd Oncology Drugs Basic Information List
Table F. Hoffmann-La Roche Ltd Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd Oncology Drugs Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Ltd Oncology Drugs Revenue Market Share in EMEA (2012-2017)
Table Icon Plc. Oncology Drugs Basic Information List
Table Icon Plc. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Icon Plc. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Icon Plc. Oncology Drugs Sales Market Share in EMEA (2012-2017)
Figure Icon Plc. Oncology Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanofi S.A. Oncology Drugs Basic Information List
Table Sanofi S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi S.A. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi S.A. Oncology Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi S.A. Oncology Drugs Revenue Market Share in EMEA (2012-2017)
Table Laboratoires Pierre Fabre Oncology Drugs Basic Information List
Table Laboratoires Pierre Fabre Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Laboratoires Pierre Fabre Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Laboratoires Pierre Fabre Oncology Drugs Sales Market Share in EMEA (2012-2017)
Figure Laboratoires Pierre Fabre Oncology Drugs Revenue Market Share in EMEA (2012-2017)
Table Eurofarma Laboratrios S.A. Oncology Drugs Basic Information List
Table Eurofarma Laboratrios S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eurofarma Laboratrios S.A. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Eurofarma Laboratrios S.A. Oncology Drugs Sales Market Share in EMEA (2012-2017)
Figure Eurofarma Laboratrios S.A. Oncology Drugs Revenue Market Share in EMEA (2012-2017)
Table Ach Laboratrios Farmacuticos S.A. Oncology Drugs Basic Information List
Table Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales Market Share in EMEA (2012-2017)
Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Revenue Market Share in EMEA (2012-2017)
Table Laboratorios IMA Oncology Drugs Basic Information List
Table Laboratorios IMA Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Laboratorios IMA Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Laboratorios IMA Oncology Drugs Sales Market Share in EMEA (2012-2017)
Figure Laboratorios IMA Oncology Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Drugs
Figure Manufacturing Process Analysis of Oncology Drugs
Figure Oncology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016
Table Major Buyers of Oncology Drugs
Table Distributors/Traders List
Figure EMEA Oncology Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Oncology Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Oncology Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Oncology Drugs Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Oncology Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Oncology Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Oncology Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Oncology Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Oncology Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Oncology Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Oncology Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Oncology Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Oncology Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Oncology Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Oncology Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Oncology Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Oncology Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Oncology Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Oncology Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Oncology Drugs Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Oncology Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Oncology Drugs Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Oncology Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.